TY  - GEN 
AU  - Rand, Kim
AU  - Ramos-Goñi, Juan Manuel
AU  - Akmaz, Bülent
AU  - Solé-Feu, Laia
AU  - Armario Hita, José Carlos
A4  - Cirugía
A4  - Medicina
PY  - 2024
SN  - 2190-9172
SN  - 2193-8210
UR  - http://hdl.handle.net/10498/32805
AB  - Authors would like to correct the Error in Fig. 1, which should illustrate that the study arms were compared in the study. As reflected in the text, these are the Q2W arm from the SOLO-CONTINUE study and the Q4W arms from the ADvocate trial. However,...
LA  - eng
PB  - Adis
TI  - Correction to: Matching-Adjusted Indirect Comparison of the Long-Term Efficacy Maintenance and Adverse Event Rates of Lebrikizumab versus Dupilumab in Moderate-to-Severe Atopic Dermatitis (Dermatology and Therapy, (2024), 14, 1, (169-182), 10.1007/s13555-023-01058-z)
DO  - 10.1007/S13555-023-01076-X
ER  -